R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Generative AI in clinical trials: Practical use cases and co...

With the hype around generative AI (GenAI), there is an increasing demand to explore its capabilities across pharma and MedTech companies, as well as contract research organisations.

R&D

The new genomic frontier: Next-generation data management ta...

Genomics is changing the world.

R&D

Neuroplastogens: A novel approach to treat neurological dise...

In the US alone, one in five adults experiences a form of mental illness each year. New medicines are urgently needed, as current therapies fail to work in up to a third of patients.

R&D

Non-opioid painkillers: Another tool to fight the opioid epi...

The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control.

R&D

Could Amazon or Google hold the key to the future of public ...

Anyone who works in medical technology knows that the industry is currently focused obsessively on two prime targets – maximising the availability of self-testing and playing its part in th

R&D

10th to 14th June – This week in clinical trials

In the latest instalment of our clinical trials round-ups, we look at life sciences research and development announced during the week of 10th to 14th June, from early-stage onwards.